Sam Ghilardi 1/6/26 Sam Ghilardi 1/6/26

What we're looking forward to in 2026

Neumora's positive clinical data , new tenants at the Arsenal, and more

Sam Ghilardi 12/16/25 Sam Ghilardi 12/16/25

Kymera and Psithera's Funding Haul

A Multi-Million dollar public offering, the developing race for a dupilumab alternative, business awards, and more.

Sam Ghilardi 12/9/25 Sam Ghilardi 12/9/25

Plus, How to design a PROTAC

Sam Ghilardi 12/2/25 Sam Ghilardi 12/2/25

Stratus Therapeutics winding down, Consider the ALS TDI for Giving Tuesday, and more

Sam Ghilardi 11/18/25 Sam Ghilardi 11/18/25

Neumora's Wegovy alternative, Dyno announces manufacturing pact, and more

Sam Ghilardi 11/4/25 Sam Ghilardi 11/4/25

Soufflé Therapeutics Launches from Stealth, Disc and Werewolf receive FDA priority, Affini-T may be winding down.